We are excited to announce the extension of our involvement in the DARPA Nucleic acids On-demand Worldwide (NOW) program. Led by GE Healthcare’s Technology and Innovation Center we will support further technology development, transfer and preparation of higher accuracy therapeutic targets with our proprietary Fully Enzymatic Synthesis™ (FES™) technology. To learn more, read the release: https://lnkd.in/ggDwQiBA #enzymaticDNAsynthesis #DNAsynthesis #DNA #DNAuncompromised #synbio
Molecular Assemblies, Inc.
Biotechnology
San Diego, California 4,161 followers
DNA Synthesis Uncompromised
About us
Molecular Assemblies, Inc. is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented Fully Enzymatic Synthesis (or FES™), based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainably. FES technology will enable the reading and writing of DNA for many industries, including industrial synthetic biology and precision medicine, as well as emerging applications of nanomachines and bio-based electronics. Molecular Assemblies is headquartered in San Diego. *Fully Enzymatic Synthesis and FES are the trademarks of Molecular Assemblies, Inc.
- Website
-
http://www.molecularassemblies.com
External link for Molecular Assemblies, Inc.
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- San Diego, California
- Type
- Privately Held
- Founded
- 2013
- Specialties
- DNA, CRISPR, Vaccines, CAR-T Therapy, DNA Synthesis, Enzymatic DNA Synthesis, Diagnostics, AgBio, SynBio, Synthetic Biology, Gene Editin, Genetic Medicines, DNA Data Storage, Cell Therapy, and Cell Therapies
Locations
-
Primary
9276 Scranton Rd
Suite 300
San Diego, California 92121, US
Employees at Molecular Assemblies, Inc.
Updates
-
"Bringing building capabilities together with design. This is going to lead to a difference in medicine, industrial materials, agriculture, and places we can't even imagine today when we can design biology with predictability, robustness, and created fast." Check out this insightful discussion with our Chairman, Larry G Stambaugh on the transformative potential of synthetic biology and the exciting future we’re building at Molecular Assemblies from last years SynBioBeta conference. #SyntheticBiology #DNASynthesis #BiotechInnovation #FutureOfScience #FES #enzymaticDNAsynthesis
What is the current state and future prospects in the field of DNA synthesis? In this session at #SynBioBeta2024, the panelists discuss the significant progress made in the field of enzymatic and chemical synthesis of DNA over the past year: https://lnkd.in/giNsiXAZ #DNA #biology
-
🚨 We’re excited to share our first FES-Forward blog post! 🚨 In the first part of a four part series focused on complex DNA sequences we delve into the challenges of synthesizing repetitive DNA sequences—an essential yet often problematic component in genomic research. Repetitive sequences play crucial roles in gene regulation, chromosome structure, and genome stability, but they also present significant obstacles in DNA synthesis and assembly. In this post, we explore innovative solutions that overcome these challenges, making it easier to work with complex sequences like those found building AAV vectors, regulatory elements, and cell models to study disorders associated with repeat expansion. Read the full post to learn more: https://lnkd.in/gb8gNcf5 #SyntheticBiology #Genomics #DNASynthesis #GeneTherapy #Innovation #AAV #Biotech #CRISPR #DNAuncompromised #DNA #FES #synbio #geneediting
-
The community has spoken, repetitive sequences are a major challenge for researchers! Whether it's Inverted Tandem Repeats (ITRs) in AAVs, repetitive promoter sequences, or long CRISPR arrays our Fully Enzymatic Synthesis (FES) technology is ready to meet these challenges. Explore our latest white paper to see for yourself, or reach out directly to collaborate on your next project. https://lnkd.in/gK53e7Uk #DNAuncompromised #enzymaticDNAsynthesis #FES #DNASynthesis #CRISPR #GeneEditing #Innovation #Biotech #synbio
First Ever Poll Alert! We're trying something new (fingers crossed it works)! We've been chatting with researchers and we're curious: which DNA sequences give you the most trouble? Vote now and let’s conquer these sequences together!
This content isn’t available here
Access this content and more in the LinkedIn app
-
Unlock the ability to synthesize even the most complex sequences. Don’t settle for ‘good enough’—achieve your research goals with precision and reliability. https://lnkd.in/gzXvNSUr Our latest white paper showcases the power of our long oligonucleotides as building blocks for successful assembly of challenging sequences, exemplified by Daniel Schindler's Lab at Max-Planck Institute for Terrestrial Microbiology and maxGENESYS Biofoundry building a complex 7-repeat CRISPR array. Other complex sequences shown include: ✔️Highly Repetitive Sequences ✔️High/Low GC Content ✔️Long Homopolymer stretches ✔️Secondary Structure Unlock the potential of your research. Download now! #DNAuncompromised #enzymaticDNAsynthesis #FES #molecularbiology #DNASynthesis #CRISPR #GeneEditing #Innovation #Biotech #synbio
-
-
First Ever Poll Alert! We're trying something new (fingers crossed it works)! We've been chatting with researchers and we're curious: which DNA sequences give you the most trouble? Vote now and let’s conquer these sequences together!
This content isn’t available here
Access this content and more in the LinkedIn app
-
We are happy to extend an invitation to come jam with us at the San Diego Biotech Networking event featuring UCSD's own Prof. Trey Ideker and The Duvets! Don’t miss this unique opportunity to connect, collaborate, and celebrate with the San Diego biotech community. Event Details: 🗓 Date: Thursday August 8th 🕔 Time: 5-7pm 📍 Location: The Bella Espresso Cocktail Lounge (2nd Floor of SCRM/UCSD across from The Salk) https://lnkd.in/gzsxFbr2 #networking #sandiegobiotech #DNAuncompromised #enzymaticDNAsynthesis #FES #DNASynthesis #synbio Complete Genomics NanoCellect Biomedical, Inc. Defined Bioscience
San Diego Biotech Networking and Jam Session featuring The Duvets!
eventbrite.com
-
Happy World RNA Day! AUG 1st – today’s date or a RNA start codon? It’s both! Today we celebrate World RNA Day as a clever nod to AUG—a codon in RNA that kickstarts protein synthesis in our cells. We honor the remarkable role of RNA in the creation of proteins, a process fundamental to life. Our long and complex DNA templates are perfect for RNA research. We specialize in creating fixed-length poly-A tails for mRNA research and other intricate in-vitro transcription (IVT) templates. Reach out to us today to learn how we can support your IVT needs and help you achieve groundbreaking results. https://lnkd.in/gAjJ_W4e
-
Join Our Team as a Marketing Associate! Are you passionate about innovative life science technology and eager to drive business growth? We are looking for a dynamic Marketing Associate to help revolutionize the biotech industry with our cutting-edge enzymatic DNA synthesis technology! Apply now and be part of something extraordinary: https://lnkd.in/gs_HSCpY
-
If you missed it, check out this insightful article featuring our CTO, Phil Paik, on the future of DNA synthesis and its transformative potential in biotech. Discover how our cutting-edge enzymatic DNA synthesis technology is revolutionizing research and opening new frontiers in genetic science.
In another Q1 installment of the Pharma's Almanac roundtable, we asked biopharma SMEs about the strategies they were using to accelerate product development and to reach commercialization without compromising on quality. See the roundtable here: https://lnkd.in/d-_S-6Qs Our panel includes experts from Alconox Inc., AVANT BIO, Evonik, GBI Bio, Hamilton Company, Lonza, Mikart, LLC, Olon, Oxford Biomedica, PPD, Samsung Biologics, Serán BioScience, TriRx Pharmaceutical Services, LLC, Waters Corporation, Wheeler Bio, Inc., 908 Devices,3PBIOVIAN, AbCellera, Agilent Technologies, Astrea Bioseparations, BASF, BioCina, BioIVT, Bioluminescence Ventures, BIOSENIC S.A., C2 PHARMA, Catalent Pharma Solutions, Cellares, CellProthera SAS, Charles River Laboratories, Core Biogenesis, Cytiva, Donaldson, eClinical Solutions, Elixirgen Therapeutics, Inc., Empress Therapeutics, Enthought, Epocrates (use this one)... (cont.)
-